Patents Represented by Attorney Schering-Plough Patent Department

Find this attorney in the Justia Lawyer Directory

  • Interleukin-10 antibodies
    Patent number: 7662379
    Abstract: The methods and compositions provided herein relate generally to IL-10 specific antibodies and uses thereof. More specifically, the methods and compositions provided herein relate to humanized IL-10 specific antibodies and methods to use such antibodies in modulating the biological activity of IL-10, particularly in autoimmune disorders and pathogen-mediated immunopathology.
    Type: Grant
    Filed: January 12, 2007
    Date of Patent: February 16, 2010
    Assignee: Schering Corporation
    Inventor: Leonard G. Presta
  • DAP12 nucleic acids
    Patent number: 7659093
    Abstract: The purification and isolation of various genes which encode mammalian cell surface polypeptides. Nucleic acids, proteins, antibodies, and other reagents useful in modulating development of cells, e.g., lymphoid and myeloid, are provided, along with methods for their use.
    Type: Grant
    Filed: December 19, 2007
    Date of Patent: February 9, 2010
    Assignee: Schering Corporation
    Inventors: Alexander B. H. Bakker, Joseph H. Phillips, Lewis L. Lanier
  • IL-B30 antibodies
    Patent number: 7608690
    Abstract: Purified genes encoding cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided.
    Type: Grant
    Filed: December 6, 2004
    Date of Patent: October 27, 2009
    Assignee: Schering Corporation
    Inventor: J. Fernando Bazan
  • Binding compounds specific for cysteine-rich soluble protein C23
    Patent number: 7560533
    Abstract: Nucleic acids encoding a new family of small cysteine rich soluble proteins, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Grant
    Filed: September 18, 2002
    Date of Patent: July 14, 2009
    Assignee: Schering Corporation
    Inventors: Karin Franz-Bacon, Daniel M. Gorman, Terrill K. McClanahan
  • IL-33 receptor
    Patent number: 7560530
    Abstract: Provided herein are methods of modulating IL-33 activity, e.g., for the purpose of treating immune diseases and conditions, as well as methods of screening for compounds capable antagonizing IL-33 signaling.
    Type: Grant
    Filed: July 18, 2007
    Date of Patent: July 14, 2009
    Assignee: Schering Corporation
    Inventors: Alissa A. Chackerian, Robert A. Kastelein
  • Method of evaluating inflammatory skin disorders using IL-17 and/or IL-19
    Patent number: 7427402
    Abstract: Provided are methods for diagnosing the propensity of a subject to develop skin inflammation, in particular, psoriasis. Also provided are methods of treatment with antagonists of IL-17, IL-19, and/or IL-23.
    Type: Grant
    Filed: December 8, 2006
    Date of Patent: September 23, 2008
    Assignee: Schering Corporation
    Inventors: Robert A. Kastelein, Terrill K. McClanahan, Erin Murphy, Jason R. Chan
  • Determination of smoothness of canisters containing inhalable medicaments
    Patent number: 7185647
    Abstract: Disclosed are methods for determining the smoothness index of the interior of a metered dose container.
    Type: Grant
    Filed: July 31, 2003
    Date of Patent: March 6, 2007
    Assignee: Schering Corporation
    Inventors: Stefan A. Sharpe, Slavka Libovicova-Tarzian, Joel A. Sequeira